RankAlpha logo
Back to Rankings

ABUS

Arbutus BiopharmaB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ABUS vs peer average
63/100
ABUS vs. peer average (B vs. C)
Grade spread
A 3 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

TBPH is the first available peer comparator.

Similar mid-cap biopharma with clinical-stage programs and comparable market cap; useful comparator for financing/valuation dynamics.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerTBPHTheravance Biopharma
ABUS
Arbutus Biopharma
TBPH
Theravance Biopharma
Grade
B
C
Momentum
66
28
Value
56
63
Sentiment
69
62
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs TBPH

ABUS / TBPH
Grade Position
In line
ABUS vs. peer average (B vs. C)
63/100
Momentum
66
ABUS
Value
56
TBPH
Sentiment
69
ABUS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ABUS
1
TBPH
TBPH
C
60/100
+1
2
ESPR
ESPR
-
-
-
3
ELVN
ELVN
F
20/100
+3
4
CADL
Candel Therapeutics Inc Common
A
100/100
-1
5
DBVT
DBV Technologies SA ADR
D
40/100
+2
TBPH is the first peer returned for this comparison set.